Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_assertion type Assertion NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_head.
- NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_assertion description "[The development of small-molecule inhibitors against TMEM16A may be clinically relevant for treatment of human cancers, including SCCHN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_provenance.
- NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_assertion evidence source_evidence_literature NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_provenance.
- NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_assertion SIO_000772 22564524 NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_provenance.
- NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_assertion wasDerivedFrom befree-20150227 NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_provenance.
- NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_assertion wasGeneratedBy ECO_0000203 NP916378.RAA2Hk0NFW9W1MX4t-hfsfCQUOvxRhVZW6M3mfsWQV08k130_provenance.